Patrick Mollon MD, MBA, MSc

Patrick Mollon, MD, ESSEC MBA, MSc acquired his medical qualification in Lyon’s School of Medicine, France where he also gained a Masters Degree in Medical and Biological Sciences, including Pharmacology, Psychology and Medical Statistics. Prior to this, he received an MBA from the Superior School of Business and Administration and Economics (ESSEC) in Paris.
He then worked as a Clinician, practicing General Medicine as well as being a Registrar in Emergency Medicine and Intensive Care in an University Teaching Hospital in Lyon, France. He started his Pharmaceutical Career in Pfizer Central Research as a Clinical Research Physician and then joined the Outcomes Research Division where he held a number of successive positions in the Product Development Group and the Medical division.
He subsequently joined Health-Economics and Outcomes Research at Novartis and Shire. Patrick has extensive experience in developing and implementing Health Economic strategies to support developmental compounds in a number of therapeutic areas, including Cardiovascular, Urology, Anti-Virals, Dermato-Immunology and Rare Diseases, leading the value identification and demonstration efforts for Market Access and Health Technology Assessment from a Global perspective. As such, he is leading the development of Patient Reported Outcomes tools, Health-Economic and Budget-Impact models, Value Dossiers and Real World Evidence.
Patrick has a number of publications in the area of Health-Economics and Outcomes Research, His main interests are in health-economic modelling methods and applications as well as patient-reported outcomes and decision-making.